86
Views
44
CrossRef citations to date
0
Altmetric
Review

Mechanisms of atherothrombosis in chronic obstructive pulmonary disease

, , &
Pages 89-96 | Published online: 07 Mar 2008

References

  • AfessaBMoralesIJScanlonPDPrognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failureCrit Care Med20023016101512130987
  • AlessandriCBasiliSVioliFHypercoagulability state in patients with chronic obstructive pulmonary disease Chronic Obstructive Bronchitis and Haemostasis GroupThromb Haemost19947234367855781
  • AndreasSAnkerSDScanlonPDNeurohumoral activation as a link to systemic manifestations of chronic lung diseaseChest200512836182416304321
  • AshitaniJMukaeHArimuraYElevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary diseaseIntern Med200241181511929177
  • BasiliSFerroniPVieriMLipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary diseaseAtherosclerosis19991472495210559510
  • BerlinerJAHeineckeJWThe role of oxidized lipoproteins in atherogenesisFree Radic Biol Med199620707278721615
  • BootsAWHaenenGRBastAOxidant metabolism in chronic obstructive pulmonary diseaseEur Respir J Suppl20034614s27s14621103
  • BorovikovaLVIvanovaSZhangMVagus nerve stimulation attenuates the systemic inflammatory response to endotoxinNature20004054586210839541
  • CalverleyPMWalkerPChronic obstructive pulmonary diseaseLancet200336210536114522537
  • CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med20073567758917314337
  • CarpagnanoGEKharitonovSAFoschino-BarbaroMPSupplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammationThorax20045910161915563698
  • CordovaCMuscaAVioliFPlatelet hyperfunction in patients with chronic airways obstructionEur J Respir Dis1985669122579841
  • DaneshJCollinsRApplebyPAssociation of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studiesJAMA19982791477829600484
  • DavìGBasiliSVieriMEnhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study GroupAm J Respir Crit Care Med1997156179499412557
  • DekhuijzenPNAbenKKDekkerIIncreased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1996154813168810624
  • DelantyNReillyMPraticoD8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivoBr J Clin Pharmacol19964215198807139
  • DevarajSHiranySVBurkRFDivergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetesClin Chem2001471974911673365
  • EickelbergORothMLorxRLigand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cellsJ Biol Chem19992741005109873044
  • EikelboomJWHirshJWeitzJIAspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular eventsCirculation20021051650511940542
  • EngstromGWollmerPHedbladBOccurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from “men born in 1914,” Malmo, SwedenCirculation200110330869111425773
  • EsmonCTDoes inflammation contribute to thrombotic events?Haemostasis200030Suppl 2344011251339
  • FimognariFLPasqualettiPMoroLThe association between metabolic syndrome and restrictive ventilatory dysfunction in older personsJ Gerontol A Biol Sci Med2007627605
  • FimognariFLPiccirilloGLamaJAssociated daily biosynthesis of cortisol and thromboxane A2: a preliminary reportJ Lab Clin Med1996128115218759943
  • FordESManninoDMProspective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up StudyDiabetes Care20042729667015562215
  • GanWQManSFSenthilselvanAAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax2004595748015223864
  • HalbertRJNatoliJLGanoAGlobal burden of COPD: systematic review and meta-analysisEur Respir J2006285233216611654
  • HansellALWalkJASorianoJBWhat do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysisEur Respir J2003228091414621089
  • HjemdahlPLarssonPTWallenNHEffects of stress and beta-blockade on platelet functionCirculation199184VI44611683610
  • HjemdahlPChronosNAWilsonDJEpinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expressionArterioscler Thromb19941477847506054
  • HoleDJWattGCDavey-SmithGImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ1996313711158819439
  • HsiaCCRaskinPThe diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulinAm J Med20051182051115745714
  • HuiartLErnstPRanouilXLow-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPDEur Respir J200525634915802336
  • JoppaPPetrasovaDStancakBSystemic inflammation in patients with COPD and pulmonary hypertensionChest20061303263316899829
  • LarssonPTWallenNHHjemdahlPNorepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirinCirculation199489195178181117
  • LawlorDAEbrahimSSmithGDAssociations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health StudyDiabetologia20044719520314704837
  • LiMZhengCSatoTVagal nerve stimulation markedly improves long-term survival after chronic heart failure in ratsCirculation2004109120414662714
  • LibbyPSimonDIInflammation and thrombosis: the clot thickensCirculation200110317182011282900
  • LofdahlCGPostmaDPrideNDoes inhaled budesonide protect against cardio-ischemic events in mild-moderate COPD: a post-hoc evaluation of the EUROSCOP Study [Abstract]European Respiratory Society Conference, Copenhagen 20052005
  • MacieCWooldrageKManfredaJInhaled corticosteroids and mortality in COPDChest2006130640616963657
  • ManSFConnettJEAnthonisenNRC-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax2006618495316738034
  • MeierCRJickSSDerbyLEAcute respiratory-tract infections and risk of first-time acute myocardial infarctionLancet19983511467719605802
  • NowakDKasielskiMAntczakAIncreased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smokingRespir Med1999933899610464820
  • NowakDKaluckaSBialasiewiczPExhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjectsFree Radic Biol Med2001301788611163535
  • OgawaSShreeniwasRBrettJThe effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant functionBr J Haematol199075517242169857
  • PasceriVWillersonJTYehETDirect proinflammatory effect of C-reactive protein on human endothelial cellsCirculation20001022165811056086
  • PatronoCThromboxane synthesis inhibitors and receptor antagonistsThromb Res Suppl19901115232148990
  • PatronoCCollerBFitzGeraldGAPlatelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest2004126234S264S15383474
  • PatronoCPatrignaniPRoccaBCharacterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical developmentThromb Haemost1995743964008578493
  • Pinto-PlataVMMullerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax20066123816143583
  • PonickeKSternitzkyRMestHJStimulation of aggregation and thromboxane A2 formation of human platelets by hypoxiaProstaglandins Leukot Med19872949593478738
  • PraticòDBasiliSVieriMChronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stressAm J Respir Crit Care Med19981581709149847257
  • RabinovichRAFiguerasMArditeEIncreased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patientsEur Respir J2003217899412765422
  • RanaJSMittlemanMASheikhJChronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in womenDiabetes Care20042724788415451919
  • RolinSMasereelBDogneJMProstanoids as pharmacological targets in COPD and asthmaEur J Pharmacol20065338910016458293
  • RussoADe LucaMVignaCCentral pulmonary artery lesions in chronic obstructive pulmonary disease: A transesophageal echocardiography studyCirculation199910018081510534469
  • Scandinavian Simvastatin Survival Study GroupRandomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet1994344138397968073
  • ScalviniSPortaRZanelliEEffects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary diseaseEur Respir J1999131192410836335
  • SinDDLacyPYorkEEffects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170760515229100
  • SinDDWuLAndersonJAInhaled corticosteroids and mortality in chronic obstructive pulmonary diseaseThorax2005a60992716227327
  • SinDDWuLManSFThe relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literatureChest2005b1271952915947307
  • TakabatakeNNakamuraHAbeSThe relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016111798410764309
  • TamaokiJKondoMNakataJEffect of a thromboxane A(2) antagonist on sputum production and its physicochemical properties in patients with mild to moderate asthmaChest200011873910893362
  • TruelsenTPrescottELangePLung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart StudyInt J Epidemiol2001301455111171876
  • van HelvoortHAHeijdraYFHeunksLMSupplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20061731122916514109
  • VestboJThe TORCH (towards a revolution in COPD health) survival study protocolEur Respir J2004242061015332386
  • WedzichaJASeemungalTAMacCallumPKAcute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost2000842101510959691
  • WedzichaJASyndercombe-CourtTanKCIncreased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemiaThorax19914650471877038
  • WeitzenblumEHirthCDucoloneAPrognostic value of pulmonary artery pressure in chronic obstructive pulmonary diseaseThorax19813675287330793
  • WoiciechowskyCAsadullahKNestlerDSympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injuryNat Med19984808139662372
  • XieMWangZPrethrombotic state in patients with chronic obstructive pulmonary disease and treatment with heparinHua Xi Yi Ke Da Xue Xue Bao1998294111410743240
  • ZoppiniGTargherGZamboniCEffects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetesNutr Metab Cardiovasc Dis200616543917126770
  • ZureikMBenetosANeukirchCReduced pulmonary function is associated with central arterial stiffness in menAm J Respir Crit Care Med20011642181511751184